日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Safety, Tolerability, and Immunogenicity of the Pneumococcal Vaccines PPSV23 or PCV15 Co-Administered with a Booster Dose of mRNA-1273 SARS-CoV-2 Vaccine in Healthy Adults ≥50 Years of Age

在≥50岁的健康成人中，肺炎球菌疫苗PPSV23或PCV15与mRNA-1273 SARS-CoV-2疫苗加强剂联合接种的安全性、耐受性和免疫原性

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines13020192
Omole, Tosin; Pelayo, Enrique; Weinberg, Aaron S; Chalkias, Spyros; Endale, Zelalem; Tamms, Gretchen; Sterling, Tina M; Good, Lori; Shekar, Tulin; Johnson, Morgan; Banniettis, Natalie; Buchwald, Ulrike K; Esteves-Jaramillo, Alejandra
肺炎
SARS-CoV-2
免疫/内分泌
发表日期：2025
文献求助 收藏

Randomized Phase 3 Trial Evaluating the Safety, Tolerability, and Immunogenicity of V114, a 15-Valent PCV, Followed by PPSV23 6 Months Later (PNEU-DAY): Subgroup Analysis in Adults 18-49 Years of Age Enrolled at Center for Indigenous Health Sites

一项随机3期试验评估了15价肺炎球菌结合疫苗V114在6个月后接种23价肺炎球菌多糖疫苗（PPSV23）的安全性、耐受性和免疫原性（PNEU-DAY）：在原住民健康中心招募的18-49岁成年人亚组分析

期刊:Vaccines
影响因子:3.4
doi:10.3390/vaccines14010003
Hammitt, Laura L; Buchwald, Ulrike K; McCauley, Jennifer; Shekar, Tulin; Fu, Wei; Cheon, Kyeongmi; Sterling, Tina; Tamms, Gretchen; Banniettis, Natalie; Musey, Luwy; LeBlanc, Jason J; Weatherholtz, Robert; Riley, Dennie Parker; Denny, Estar; Tso, Carol; Roessler, Kristen; Santosham, Mathuram
肺炎
免疫/内分泌
发表日期：2025
文献求助 收藏

A Phase 3, Randomized, Double-Blind, Comparator-Controlled Study to Evaluate Safety, Tolerability, and Immunogenicity of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Allogeneic Hematopoietic Cell Transplant Recipients (PNEU-STEM)

一项评估 15 价肺炎球菌结合疫苗 V114 在同种异体造血干细胞移植受者中的安全性、耐受性和免疫原性的 3 期随机、双盲、对照研究 (PNEU-STEM)

期刊:Clinical Infectious Diseases
影响因子:7.3
doi:10.1093/cid/ciad349
Wilck, Marissa; Cornely, Oliver A; Cordonnier, Catherine; Velez, Juan Diego; Ljungman, Per; Maertens, Johan; Selleslag, Dominik; Mullane, Kathleen M; Nabhan, Samir; Chen, Qiuxu; Dagan, Ron; Richmond, Peter; Daus, Caroline; Geddie, Kateasha; Tamms, Gretchen; Sterling, Tina; Patel, Shrita M; Shekar, Tulin; Musey, Luwy; Buchwald, Ulrike K
肺炎
发育与干细胞
干细胞
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏

Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in at-risk adults 18-49 years of age (PNEU-DAY): A subgroup analysis by baseline risk factors

一项评估15价肺炎球菌结合疫苗V114（接种后6个月接种23价肺炎球菌多糖疫苗）在18-49岁高危成年人群中的安全性、耐受性和免疫原性的3期临床试验（PNEU-DAY）：按基线风险因素进行的亚组分析

期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2023.2177066
Hammitt, Laura L; Quinn, Dean; Janczewska, Ewa; Pasquel, Francisco J; Tytus, Richard; Reddy, K Rajender; Abarca, Katia; Khaertynova, Ilsiyar M; Dagan, Ron; Dawson, Rachel; McCauley, Jennifer; Shekar, Tulin; Fu, Wei; Pedley, Alison; Sterling, Tina; Tamms, Gretchen; Musey, Luwy; Buchwald, Ulrike K
肺炎
免疫/内分泌
发表日期：2023
文献求助 收藏

Safety and Immunogenicity of V114 in Preterm Infants: A Pooled Analysis of Four Phase Three Studies

V114 在早产儿中的安全性和免疫原性：四项 III 期研究的汇总分析

期刊:Pediatric Infectious Disease Journal
影响因子:2.2
doi:10.1097/INF.0000000000004069
Chapman, Timothy J; Patel, Shrita M; Flores, Sheryl A; Xu, Shengjie; Lupinacci, Robert; Shi, Yaru; Shekar, Tulin; Feemster, Kristen; Yi, Jumi; Tamms, Gretchen; Kaminski, Janusz; Bickham, Kara; Musey, Luwy; Buchwald, Ulrike K; Banniettis, Natalie
免疫/内分泌
发表日期：2023
文献求助 收藏

Immunogenicity, Safety, and Tolerability of V114, a 15-Valent Pneumococcal Conjugate Vaccine, in Immunocompetent Adults Aged 18-49 Years With or Without Risk Factors for Pneumococcal Disease: A Randomized Phase 3 Trial (PNEU-DAY)

V114（一种 15 价肺炎球菌结合疫苗）在 18-49 岁免疫功能正常的成年人（无论是否具有肺炎球菌疾病风险因素）中的免疫原性、安全性和耐受性：一项随机 3 期试验 (PNEU-DAY)

期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofab605
Hammitt, Laura L; Quinn, Dean; Janczewska, Ewa; Pasquel, Francisco J; Tytus, Richard; Rajender Reddy, K; Abarca, Katia; Khaertynova, Ilsiyar M; Dagan, Ron; McCauley, Jennifer; Cheon, Kyeongmi; Pedley, Alison; Sterling, Tina; Tamms, Gretchen; Musey, Luwy; Buchwald, Ulrike K
肺炎
免疫/内分泌
发表日期：2022
文献求助 收藏

Safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, administered concomitantly with influenza vaccine in healthy adults aged ≥50 years: a randomized phase 3 trial (PNEU-FLU)

在 ≥50 岁的健康成年人中，同时接种 15 价肺炎球菌结合疫苗 V114 与流感疫苗的安全性、耐受性和免疫原性：一项随机 3 期试验 (PNEU-FLU)

期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2021.1976581
Severance, Randall; Schwartz, Howard; Dagan, Ron; Connor, Laurie; Li, Jianing; Pedley, Alison; Hartzel, Jonathan; Sterling, Tina M; Nolan, Katrina M; Tamms, Gretchen M; Musey, Luwy K; Buchwald, Ulrike K
肺炎
免疫/内分泌
流感
微生物学
发表日期：2022
文献求助 收藏

Sequential administration of Prevnar 13™ and PNEUMOVAX™ 23 in healthy participants 50 years of age and older

在50岁及以上健康受试者中依次接种沛儿13™和肺炎球菌疫苗23™

期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2021.1888621
Buchwald, Ulrike K; Andrews, Charles P; Ervin, John; Peterson, James T; Tamms, Gretchen M; Krupa, David; Ajiboye, Patrick; Roalfe, Lucy; Krick, Andrea L; Sterling, Tina M; Wang, Meihua; Martin, Jason C; Stek, Jon E; Kohn, Melvin A; Folaranmi, Temitope; Abeygunawardana, Chitrananda; Hartzel, Jonathan; Musey, Luwy K
肺炎
发表日期：2021
文献求助 收藏

Safety and immunogenicity of 15-valent pneumococcal conjugate vaccine compared to 13-valent pneumococcal conjugate vaccine in adults ≥65 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine

在既往接种过23价肺炎球菌多糖疫苗的≥65岁成人中，15价肺炎球菌结合疫苗与13价肺炎球菌结合疫苗的安全性和免疫原性比较

期刊:Human Vaccines & Immunotherapeutics
影响因子:3.5
doi:10.1080/21645515.2018.1532250
Peterson, James T; Stacey, Helen L; MacNair, John E; Li, Jianing; Hartzel, Jonathan S; Sterling, Tina M; Benner, Patrice; Tamms, Gretchen M; Musey, Luwy K
肺炎
免疫/内分泌
发表日期：2019
文献求助 收藏